Gitelson D. G. (RUDN University; National Hematology Research Center)
Faibushevich A. G. (RUDN University)
Maximkin D. A (RUDN University)
Veretnik G. I. (RUDN University)
Baranovich V. Yu. (RUDN University)
Gitelzon E. A. (RUDN University)
Vasiliev A. E. (National Hematology Research Center)
Danishian K. I. (National Hematology Research Center)
|
Coronary stenting is a common and effective treatment for patients with ischemic heart disease. However, stent thrombosis and bleeding are dangerous complications of coronary artery stenting. Dual antiplatelet therapy can prevent complications before and long after stenting. Nevertheless, laboratory data show that it is not effective in all patients. The purpose of this review is to describe the current understanding and research results of personalized dual antiplatelet therapy.
Keywords:Ischemic heart disease, personalized antiplatelet therapy, coronary stenting.
|
|
|
Read the full article …
|
Citation link: Gitelson D. G., Faibushevich A. G., Maximkin D. A., Veretnik G. I., Baranovich V. Y., Gitelzon E. A., Vasiliev A. E., Danishian K. I. Personalized antiplatelet therapy for coronary artery stenting // Современная наука: актуальные проблемы теории и практики. Серия: Естественные и Технические Науки. -2020. -№10. -С. 144-150 DOI 10.37882/2223-2966.2020.10.09 |
|
|